COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,788 Articles (22,523 medRxiv, 8,265 bioRxiv)

Most recent first Previous |  Page 1510: Articles 15091-15100  | Next

COVID-19 infection and hospitalization according to the burden of chronic noncommunicable diseases in Brazil
Ferraz, F. R., Venancio, I., Lopes, L. N., Azeredo, C., Conde, w.
10.1101/2021.05.03.21256532 — Posted: 2021-05-05
Outbreaks of Covid-19 Variants in Prisons: A Mathematical Modeling Analysis of Vaccination and Re-Opening Policies
Ryckman, T. S., Chin, E. T., Prince, L., Leidner, D., Long, E., Studdert, D. M., Salomon, J. A., Alarid-Escudero, F., Andrews, J. R., Goldhaber-Fiebert, J. D.
10.1101/2021.05.03.21256525 — Posted: 2021-05-05
Implementation of SARS-CoV2 Screening in K-12 Schools using In-School Pooled Molecular Testing and Deconvolution by Rapid Antigen Test
Pollock, N. R., Berlin, D., Smole, S. C., Madoff, L. C., Henderson, K., Larsen, E., Hay, J., Gabriel, S., Gawande, A. A., Lennon, N.
10.1101/2021.05.03.21256560 — Posted: 2021-05-05
Population behavioural dynamics can mediate the persistence of emerging infectious diseases
Fair, K. R., Karatayev, V. A., Anand, M., Bauch, C.
10.1101/2021.05.03.21256551 — Posted: 2021-05-05 Discussion: Onsite
Analysis and visualization of epidemics on the timescale of burden: derivation and application of Epidemic Resistance Lines (ERLs) to COVID-19 outbreaks in the US
Washburne, A. D., Silverman, J. D., Lourenco, J., Hupert, N.
10.1101/2021.05.03.21256542 — Posted: 2021-05-05
Roles of generation-interval distributions in shaping relative epidemic strength, speed, and control of new SARS-CoV-2 variants
Park, S. W., Bolker, B. M., Funk, S., Metcalf, C. J. E., Weitz, J. S., Grenfell, B. T., Dushoff, J.
10.1101/2021.05.03.21256545 — Posted: 2021-05-05
Cesarean section prevalence at a baby-friendly hospital in southern Brazil: current context in the face of COVID-19
Bicho, M. d. A., Fernandes, M., Vidaletti, L. P., Vaz, J. d. S.
10.1101/2021.05.03.21256516 — Posted: 2021-05-05
Investigating the relationship between serum ACE 2 level and COVID-19 patients' prognosis: a cross-sectional study
Mohammadi, P., Varpaei, H. A., Seifi, A., Zahak Miandoab, S., Beiranvand, S., Mobaraki, S., Mohammadi, M.
10.1101/2021.05.02.21256329 — Posted: 2021-05-05
Protocol of the COVID-19 Health Adherence Research in Scotland Vaccination (CHARIS-V) study: Understanding the influence of vaccination decisions on adherence to transmission-reducing behaviours in a prospective longitudinal study of the Scottish Population.
Maciver, M., Den Daas, C., Johnston, M., Dixon, D., Hubbard, G.
10.1101/2021.05.03.21256503 — Posted: 2021-05-05
ROCCA study protocol and interim analysis on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino: an observational study using active surveillance
Montalti, M., Solda, G., Di Valerio, Z., Salussolia, A., Lenzi, J., Forcellini, M., Barvas, E., Guttmann, S., Messina, R., Poluzzi, E., Raschi, E., Riccardi, R., Fantini, M. P., La Fauci, G., Gori, D., San Marino Republic COVID ROCCA Group
10.1101/2021.05.03.21256509 — Posted: 2021-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).